Skip to main content
Clinical Trials/ACTRN12621001317886
ACTRN12621001317886Not yet recruiting未知

The effect of the vaccine for COVID-19 on menstrual cycle symptoms in healthy women

Endometriosis research group, The Royal Women's hospital VIC0 sites1,200 target enrollmentStarted: September 28, 2021Last updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor
Enrollment
1,200

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to 45 Years (—)
Sex
Female

Inclusion Criteria

  • Premenopausal individuals who have had at least one period in the past
  • Currently having periods or
  • Currently not having periods due to other reasons eg. using hormonal contraceptives, using gender affirming hormones
  • Have not yet been vaccinated but are planning on having the COVID-19 vaccine soon or have received their first dose on day of recruitment
  • Healthy people (without blood disorders or known hematological diseases)
  • Aged 18-45
  • Interested in participating in the study and consent to regular monitoring of their menstruation.

Exclusion Criteria

  • People who are already vaccinated against COVID
  • People who never had periods
  • People who are post menopausal, pregnant, breastfeeding or who plan pregnancy in the next 12 months.
  • People who have had a hysterectomy

Investigators

Sponsor
Endometriosis research group, The Royal Women's hospital VIC

Similar Trials